Insider trading

Period: 120 months Stock: IDYA Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

42 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

42 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

42 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

42 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
42 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
42 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

42 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
7 Jul 2026
Ruiz Briseno Andres Chief Accounting Officer
Sold on a plan
$382.13K 9,550 at 40.01
26.5%
Planned (10b5-1)
29 May 2024
WHITE MICHAEL ANTHONY Chief Scientific Officer
Sold on a plan 2×
$1.03M 28,500 at 36.24
100%
Sold half or more
9 Feb 2024
Ruiz Briseno Andres See Remarks
Sold on a plan
$92.04K 2,000 at 46.02
7.5%
Planned (10b5-1)
22 Jan 2024
Ruiz Briseno Andres See Remarks
Sold on a plan
$84.05K 2,000 at 42.03
7.0%
Planned (10b5-1)
12 Jan 2024
Ruiz Briseno Andres See Remarks
Sold on a plan
$76.03K 2,000 at 38.01
6.6%
Planned (10b5-1)
15 Dec 2023
Throne Jason Chief Legal Officer
Sold on a plan
$350.37K 10,000 at 35.04
100%
Sold half or more
14 Dec 2023
Ruiz Briseno Andres See Remarks
Sold on a plan 2×
$68.00K 2,000 at 34.00
6.1%
Planned (10b5-1)
3 Nov 2023
Throne Jason Chief Legal Officer
Sold on a plan
$155.36K 5,163 at 30.09
100%
Sold half or more
12 Sep 2023
Throne Jason Chief Legal Officer
Sold on a plan 2×
$30.01K 1,000 at 30.01
100%
Sold half or more
5 Sep 2023
Throne Jason Chief Legal Officer
Sold on a plan
$52.16K 1,737 at 30.03
100%
Sold half or more
1 Sep 2023
Throne Jason Chief Legal Officer
Sold on a plan
$63.06K 2,100 at 30.03
100%
Sold half or more
1 Sep 2023
Ruiz Briseno Andres See Remarks
Sold on a plan
$60.02K 2,000 at 30.01
5.8%
Planned (10b5-1)
9 Aug 2023
Throne Jason Chief Legal Officer
Sold on a plan
$125.43K 5,000 at 25.09
100%
Sold half or more
10 Jul 2023
Throne Jason Chief Legal Officer
Sold on a plan
$218.18K 9,485 at 23.00
100%
Sold half or more
1 Jun 2023
Throne Jason Chief Legal Officer
Sold on a plan
$81.79K 3,553 at 23.02
100%
Sold half or more
31 May 2023
Throne Jason Chief Legal Officer
Sold on a plan
$9.94K 432 at 23.00
100%
Sold half or more
22 May 2023
Throne Jason Chief Legal Officer
Sold on a plan
$11.50K 500 at 23.00
100%
Sold half or more
4 Oct 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated 2×
$39.55K 1,500 at 26.36
1.9%
8 Sep 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated 2×
$312.09K 11,384 at 27.42
12.6%
7 Sep 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated
$3.19K 116 at 27.46
0.1%
2 Sep 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated
$250.94K 10,000 at 25.09
11.3%
9 Aug 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated 2×
$264.27K 11,500 at 22.98
11.5%
27 Jul 2021
Throne Jason SVP, General Counsel
Sold, plan not stated
$251.68K 10,000 at 25.17
100%
Sold half or more
27 Jul 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated
$251.46K 10,000 at 25.15
9.2%
6 Jul 2021
Throne Jason SVP, General Counsel
Sold, plan not stated 4×
$222.41K 10,000 at 22.24
100%
Sold half or more
6 Jul 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated 2×
$33.36K 1,500 at 22.24
1.5%
17 Jun 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated
$87.54K 3,893 at 22.49
3.8%
16 Jun 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated
$24.87K 1,107 at 22.47
1.1%
7 Jun 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated
$30.33K 1,500 at 20.22
1.5%
11 May 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated
$101.09K 5,000 at 20.22
4.8%
10 Feb 2021
Lackner Mark SVP, Head of Biology
Sold, plan not stated
$12.52K 596 at 21.00
100%
Sold half or more
9 Feb 2021
Dillon Michael P. SVP, Chief Scientific Officer
Sold, plan not stated
$103.70K 5,000 at 20.74
4.8%
9 Feb 2021
Lackner Mark SVP, Head of Biology
Sold, plan not stated
$23.23K 1,104 at 21.05
100%
Sold half or more
8 Feb 2021
Lackner Mark SVP, Head of Biology
Sold, plan not stated 2×
$6.30K 300 at 21.01
100%
Sold half or more
2 Feb 2021
BVF PARTNERS L P/IL See Explanation of Responses
Sold, plan not stated 3×
$835.36K 46,409 at 18.00
16.6%
26 Jan 2021
Lackner Mark SVP, Head of Biology
Sold, plan not stated 2×
$46.16K 2,501 at 18.46
100%
Sold half or more
4 Dec 2020
Throne Jason SVP, General Counsel
Sold, plan not stated 2×
$30.41K 1,979 at 15.37
100%
Sold half or more
17 Jun 2020
Lackner Mark SVP, Head of Biology
Sold, plan not stated
$7.43K 373 at 19.91
100%
Sold half or more
16 Jun 2020
Lackner Mark SVP, Head of Biology
Sold, plan not stated
$100.76K 6,750 at 14.93
100%
Sold half or more
4 Jun 2020
Throne Jason VP, General Counsel
Sold, plan not stated
$19.09K 2,205 at 8.66
100%
Sold half or more
2 Jun 2020
Lackner Mark SVP, Head of Biology
Sold, plan not stated 3×
$7.78K 845 at 9.21
100%
Sold half or more
28 May 2019
Stone Paul A. SVP, General Counsel · indirect
Bought 2×
$2.50M 250,000 at 10.00
9.6%
First buy on file
Showing 1–42 of 42.